Gossamer Bio, Inc.: DeepCurrents Investment Group LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
DeepCurrents Investment Group LLC amended its Schedule 13G filing on Gossamer Bio, Inc., updating its passive stake disclosure with the SEC under accession number 0001104659-26-128345. The filing signals a change in the investment firm's reported position in the clinical-stage biopharmaceutical company. Schedule 13G amendments are typically filed when a passive investor's ownership crosses the 5% threshold or when previously reported holdings change materially. Investors will watch for further 13G or 13D filings to gauge whether DeepCurrents is building or trimming its position in Gossamer Bio.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
DeepCurrents Investment Group LLC, Gossamer Bio, Inc.